Latest Anas Younes Stories
Phase I trial establishes dose, catalogues side effects, hints at targeted drug's potential An antibody loaded with an anti-cancer agent produced complete or partial remissions in 38 percent of patients with relapsed or therapy-resistant Hodgkin lymphoma enrolled in a phase I clinical trial, investigators report in the Nov. 4 issue of the New England Journal of Medicine. "That level of objective responses to a drug is impressive for a Phase I trial," said study lead author Anas Younes, M.D.,...
- A stinking tobacco.
- Offal; waste animal product; organic matter unfit for consumption.